Advertisement
Singapore markets close in 3 hours 5 minutes
  • Straits Times Index

    3,326.48
    +19.04 (+0.58%)
     
  • Nikkei

    38,786.50
    -90.21 (-0.23%)
     
  • Hang Seng

    18,021.31
    +83.47 (+0.47%)
     
  • FTSE 100

    8,215.48
    +67.67 (+0.83%)
     
  • Bitcoin USD

    67,549.38
    +285.04 (+0.42%)
     
  • CMC Crypto 200

    1,424.03
    +28.98 (+2.08%)
     
  • S&P 500

    5,421.03
    +45.71 (+0.85%)
     
  • Dow

    38,712.21
    -35.21 (-0.09%)
     
  • Nasdaq

    17,608.44
    +264.89 (+1.53%)
     
  • Gold

    2,326.20
    -28.60 (-1.21%)
     
  • Crude Oil

    78.27
    -0.23 (-0.29%)
     
  • 10-Yr Bond

    4.2950
    -4.4040 (-50.63%)
     
  • FTSE Bursa Malaysia

    1,613.14
    +4.19 (+0.26%)
     
  • Jakarta Composite Index

    6,865.43
    +15.33 (+0.22%)
     
  • PSE Index

    6,430.81
    +20.74 (+0.32%)
     

The Zacks Analyst Blog Highlights Lilly, Honeywell International. American Express, Lowe's Companies and Airbnb

For Immediate Release

Chicago, IL – March 24, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Lilly and Co. LLY, Honeywell International Inc. HON, American Express Co. AXP, Lowe's Companies, Inc. LOW and Airbnb, Inc. ABNB.

Here are highlights from Thursday’s Analyst Blog:

Top Analyst Reports for Eli Lilly, Honeywell and American Express

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co., Honeywell International Inc. and American Express Co.. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today's research reports here >>>

Eli Lilly's shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+16.4% vs. +1.8%). The company boasts a solid portfolio of core drugs in diabetes, autoimmune diseases and cancer. Its revenue growth is being driven by higher demand for drugs like Trulicity, Taltz and others.

It is regularly adding promising new pipeline assets through business development deals. Lilly expects to launch four new medicines by 2023 end, with Mounjaro for type II diabetes already launched and cancer drug Jaypirca already approved. Mounjaro is off to a solid start.

However, the CRL for donanemab will probably delay the potential launch of the candidate. Generic competition for several drugs, rising pricing pressure in the U.S. and some international markets are some top-line headwinds.

(You can read the full research report on Eli Lilly here >>>)

Shares of Honeywell International have outperformed the Zacks Diversified Operations industry over the past six months (+10.1% vs. +3.4%). Due to a recovery in commercial flight hours, strength in its advanced materials business and improvement in process technologies augur well for the company's growth.

Pricing actions and cost-control measures continue to drive the company's top line. The company's bullish forecast for 2023 holds promise. Efforts to handsomely reward shareholders with dividends and share buybacks are attractive, as well.

However, volume softness due to supply-chain disruptions, especially semiconductor and parts shortages, is concerning. Weakness in the Safety and Productivity Solutions unit, due to lower personal protective equipment and warehouse automation volumes, is also worrisome. Raw material cost inflation and adverse foreign currency movements are other headwinds.

(You can read the full research report on Honeywell International here >>>)

Shares of American Express have outperformed the Zacks Financial - Miscellaneous Services industry over the past six months (+18.5% vs. +3.6%). The company has adopted several growth initiatives, such as launching new products, enhancing existing features, reaching new agreements and forging alliances to boost revenues.

The Zacks analyst expects the top line to grow 15% year over year in 2023. Consumer spending on travel and entertainment, which carry higher margins for AmEx, is advancing well. Its balance sheet looks strong with manageable debt. Solid cash-generation abilities enable the pursuit of business investments and capital deployment.

However, with higher utilization of the company's cards, expenses in card member services and rewards is likely to go up and dent the company's margins. Also, marketing and business development expenses are expected to rise. As such, the stock warrants a cautious stance.

(You can read the full research report on American Express here >>>)

Other noteworthy reports we are featuring today include Lowe's Companies, Inc. and Airbnb, Inc..

ADVERTISEMENT

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                       

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Honeywell International Inc. (HON) : Free Stock Analysis Report

Eli Lilly and Company (LLY) : Free Stock Analysis Report

American Express Company (AXP) : Free Stock Analysis Report

Lowe's Companies, Inc. (LOW) : Free Stock Analysis Report

Airbnb, Inc. (ABNB) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research